Instead, in breast cancer cells, PEITC can target breast cancer stem cells through the epigenetic reactivation of cadherin 1, a tumor suppressor gene, by inhibiting DNMT and HDAC activity, thus demethylating its promoter site [136]. The gene discussed is HDAC9; the disease is neoplasm.